| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54K | -65.6% |
| SG&A Expense | $889K | -11.0% |
| Operating Income | -$943K | +18.4% |
| Net Income | -$1.5M | +13.3% |
| EPS (Basic) | $0.00 | +100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25K | -59.4% |
| Current Assets | $28K | -54.6% |
| Total Assets | $28K | -54.6% |
| Current Liabilities | $10.8M | +8.2% |
| Stockholders' Equity | -$10.7M | -8.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$497K | +37.3% |
| Financing Cash Flow | $461K | -45.9% |